Use of Levosimendan in patients with INTERMACS 3 profile: weaning from inotropic support and short- to medium-term evolution

Autor: Enachi, S, Bochaton, T, Hayek, A, Prieur, C, Tomasevic, D, Scheppler, B, Bonnefoy Cudraz, E, Jobbe Duval, A
Zdroj: European Heart Journal Acute Cardiovascular Care; April 2024, Vol. 13 Issue: 1, Number 1 Supplement 1
Databáze: Supplemental Index